The Closer – Super Lose – 3/3/20
Log-in here if you’re a member with access to the Closer.
Looking for deeper insight on markets? In tonight’s Closer sent to Bespoke Institutional clients, we take a look at the market reaction to today’s rate cuts and where equities stand relative to short term rates. We then take a look at the record low yields in the US and abroad. Next, we show just how much bonds have outperformed equities before reviewing credit markets. We finish by looking through derivative markets.
See today’s post-market Closer and everything else Bespoke publishes by starting a 14-day free trial to Bespoke Institutional today!
S&P 500 Dividend Yield Now 100+ Basis Points Higher Than 10-Year Treasury Yield
The yield on the 10-Year Treasury tipped below 1% today for the first time ever as the Fed cut rates by 50 bps. That is a record low yield for the 10 Year. Meanwhile, the past few days have seen the S&P 500’s dividend yield rise to some of its highest levels in over a year. This leaves the S&P’s dividend yield at 2.1% today. That means holding the various levels of risk and other factors constant, stocks are yielding over 1% more than the 10-Year yield. That sharp divergence in yields is shown in the chart below.
Since the mid-2000s, the spread between the S&P’s dividend yield and the 10-year yield has only moved above one on one other occasion, and that was near the depths of the Financial Crisis in December 2008. Start a two-week free trial to Bespoke Institutional to access our interactive tools and full library of research.
Covid-19 Cases and Mortality Rates By Country
One of the factors that makes it so hard for investors to grapple with the Covid-19 coronavirus is that there really aren’t very good numbers related to the mortality rate, and if you look at the mortality rates by individual countries, they vary widely. Reasons for the variance range from lack of available testing infrastructure to a general distrust of statistics being reported by certain governments. With those two caveats in mind, a look at current infection and mortality rates shows a disconcerting picture from a US perspective. The table below shows the number of cases and deaths due to the coronavirus broken down by country. These figures were pulled from the incredibly useful Johns Hopkins Coronavirus monitor, and we only included countries that have reported more than ten cases of Covid-19.
The table below is sorted by mortality rate from highest to lowest, and here is one case where the US doesn’t want to be winning. With a current rate of 5.6%, the mortality rate from confirmed Covid-19 cases in the US is higher than any other country in the world including Iran which comes in at 3.3%. Obviously, the lack of available testing in the US from a shortage of test kits has resulted in fewer tests than other countries, so the number of confirmed cases in the US is likely a lot lower than the number currently flowing around undetected. However, the fact that the US even finds itself here in the first place isn’t the most comforting thing for Americans already worried about the spread of the virus! Receive full access to all of our analysis, including the latest coronavirus news and how it’s impacting the markets, by signing up for a free two-week free trial to Bespoke Institutional today.
The chart below shows the ten countries/regions with the highest mortality rates from the Covid-19 outbreak. The US is nearly a full two percentage points above China (3.7%) and a full three percentage points above every other country besides Iran. Again, as testing expands in the US, the number of cases will undoubtedly rise as milder cases are detected, but even in that case, testing procedures capacity in the US should have been a lot faster to ramp up.
Homebuilders Appear Attractive As Rates Move Lower
Earlier today we updated our weekly Stock Scores, which ranks each of the stocks in the S&P 1500 based on various fundamental, technical, and sentiment factors. Coincidentally on the same day that the Federal Reserve surprised with a 50 bps rate cut, one group of stocks poised to benefit from lower rates, the homebuilders, came in with very strong scores. As shown in the chart below, breaking down the S&P 1500 by the GICS Level 4 Sub-Industries, the average stock in the homebuilder sub-industry had a score of 65.9 (out of 100). That is higher than any other group with the next highest-ranked sub-industry being Heavy Electrical Equipment. Another interesting group to note is Airlines, which despite having been crushed in the coronavirus fallout, surprisingly find themselves in the top ten.
The strength in Airlines is due in large part to high fundamental ratings for stocks in the group. Those high scores don’t fully take into account the weaker earnings that the market is pricing in, but unlike prior periods over time, airlines as a whole are in a lot better financial shape than they were in the past.
Looking at just the homebuilder stocks, Taylor Morrison Home (TMHC) boasts the highest total score this week at 81.1 thanks to strong fundamental, technical, and sentiment scores. TMHC has such a strong score this week that it also places second out of all S&P 1500 stocks. Several others have similarly strong fundamental scores, but only DR Horton (DHI) has a flawless technical score.
While equities more generally have traded violently in the last two weeks, they have moved decidedly lower this afternoon, even after the FOMC cut rates. The homebuilders, however, have been the exception . Following steep declines last week, the Homebuilders ETF (ITB) fell back down to the 200-DMA for the first time in nearly a year. That level acted as support, though, as ITB bounced off that level over the past couple of sessions. This bounce has been helped further today by low rates providing a stimulus to the industry. This is as already low mortgage rates have led to housing being a bright spot for the economy. Looking ahead, the next resistance to watch for ITB would be the 50-DMA. If you’d like full access to our weekly Stock Scores ratings, start a two-week free trial to Bespoke Institutional today.
Bespoke’s Morning Lineup – 3/3/20 – Two for Tuesday?
See what’s driving market performance around the world in today’s Morning Lineup. Bespoke’s Morning Lineup is the best way to start your trading day. Read it now by starting a two-week free trial to Bespoke Premium. CLICK HERE to learn more and start your free trial.
The market was hoping for more than a statement from the G7 this morning, but that’s all it got for now. As a result, positive action in the futures market quickly headed south. Things have bounced back quite a bit from the initial reaction as current indications suggest a modestly weaker open…for now.
Read today’s Bespoke Morning Lineup for the latest on Biden’s surge in the political polls ahead of Super Tuesday, news on coronavirus, and the latest stock-specific events.
The S&P 500 is already up over 4% MTD, and if yesterday’s gains don’t hold it would mark a truly momentous milestone for the S&P 500. That’s because we have already seen two straight months where the S&P 500 was up over 3% MTD but finished down in a given month. In the entire history of the S&P 500, there have only been four periods of back to back months where we have seen similar reversals with the most recent occurrence back in January and February of 2009. In case you were curious, there were only three other months in between these two periods where we saw a similar reversal in a single month (October 2009, January 2010, and November 2010).
Looking at the prior back to back monthly negative reversals, the S&P 500 was higher six months later three out of four times. The only negative period was in May and June of 1973 when the S&P 500 fell 6.4% over the next six months and 17.5% over the next year.

The Closer – Fear Sent Flying as Stocks, Commodities, & Rates Surge – 3/2/20
Log-in here if you’re a member with access to the Closer.
Looking for deeper insight on markets? In tonight’s Closer sent to Bespoke Institutional clients, we begin with a look at today’s rally in historical context before reviewing the price action of the VIX, rates, crude oil, copper, and high yield bonds. We then turn to US politics to look at where the Democratic candidates stand headed into Super Tuesday. We then show how consumer sentiment has been impacted by the coronavirus. We finish with a look at today’s construction spending data.
See today’s post-market Closer and everything else Bespoke publishes by starting a 14-day free trial to Bespoke Institutional today!
Not a Normal Bounce Back Day
The large-cap Russell 1,000 was up 4.35% on the day, but notably, the average stock in the index was up much less than that at just +3.25%. The reason for the big performance divergence is because the largest ten stocks in the index were up an average of 5.29% on the day. A cap-weighted index that’s as top-heavy as it is now benefits greatly when its largest members outperform, and that’s what happened today. The two trillion-dollar companies in the index — Apple (AAPL) and Microsoft (MSFT) — were up 9.31% and 6.65%, respectively.
Normally on big bounce-back days, the stocks that got hit the hardest during the selloff bounce back the most. That didn’t happen today. Below we’ve broken the Russell 1,000 into deciles (10 groups of 100 stocks each) based on share price performance during the massive selloff we saw from the market’s peak on 2/19 through last Friday (2/28). The stocks that fell the most during the selloff (decile 10) actually bounced the least today, rising just 1.92% on average.
Below is a table showing the thirty best-performing stocks in the Russell 1,000 today. For each stock, we also show how it performed during the 2/19-2/28 selloff as well as its current market cap. Four stocks in the Russell 1,000 were up 10%+ today. Vaccine-maker Moderna (MRNA) was up the most with a gain of 15.23%, adding to the 37.05% it gained from 2/19-2/28. Sage Therapeutics (SAGE) was up the second most at +13.53%, followed by Tesla (TSLA) at +11.32%. Tesla buyers were back out in full force after suffering through a 27% decline from 2/19-2/28. Finally, medical waste disposal company Stericycle (SRCL) was up the fourth most with a gain of 10.74% today.
Costco (COST) and Apple (AAPL) were the 5th and 6th best performers in the Russell 1,000 today with gains of 9.96% and 9.31%, respectively. Other notables on the list of biggest winners today include S&P Global (SPGI), Gilead (GILD), Scotts Miracle-Gro (SMG), Moody’s (MCO), Clorox (CLX), Twitter (TWTR), and Church & Dwight (CHD). From Health Care to Consumer Staples to Tech, a large number of sectors were represented. However, one sector with no names on the list of best performers today was Energy. What else is new? See our most actionable market analysis with a Bespoke Premium membership. Click here to start a two-week free trial now.
The Impact of COVID-19 on Earnings Reports
Below is a look at the historical earnings beat rate (vs. consensus analyst estimates) for US companies reporting quarterly numbers on a rolling 3-month basis. These charts are updated on a regular basis at our popular Earnings Explorer tool. The first chart shows the bottom-line EPS beat rate, while the second chart shows the top-line revenue beat rate. Prior to the last week or so, beat rates had been on the upswing, but they’ve taken a slight dip since the market peaked on February 19th.
The reading that has really taken a hit since the COVID-19 virus began to spread is forward guidance. The chart below shows our Guidance Spread tracker from our Earnings Explorer tool, which looks at the difference between the number of companies raising guidance and lowering guidance on a rolling three-month basis. As shown, our guidance spread has fallen dramatically over just the last three weeks, which coincides with the rapid outbreak of the coronavirus both inside and outside of China. At this point, our guidance spread has taken out lows seen in November 2019, but it’s not nearly as negative as it was in the early part of 2019.
Along with the big drop in our guidance spread tracker, share price reactions to earnings reports have also taken a big hit. The chart below shows the median one-day share price change that stocks have experienced on their earnings reaction days on a rolling three-month basis. Over the last three months, the median share price change for stocks on their earnings reaction days has been -0.56%. That’s the most negative reading seen in the last twelve months, and it’s a complete reversal of the trend of positive share-price reactions we were seeing as recently as January. Stocks have gone from reacting very positively to their earnings reports to reacting very negatively to their earnings reports in just a few weeks. You can see these charts over a longer time frame at our Earnings Explorer page, which is available to Bespoke Institutional members. Start a two-week free trial to Bespoke Institutional to access our Earnings Explorer, the rest of our interactive investor tool-kit, and our actionable investment research.
Covid-19 Slowing Manufacturing
Similar to the final Markit readings for the month of February released this morning, the headline February ISM Manufacturing number has yet to show any major negative impact as a result of the coronavirus outbreak. The headline index was expected to fall to 50.5 from 50.9, but the actual decline was larger down to 50.1. Despite the weaker than expected reading, the ISM Manufacturing index remains at expansionary levels, and it is also a stronger reading than most months since the second half of 2019.
While the headline number may not flash any huge negative impacts from the coronavirus, the commentary section of February’s report makes frequent mention with respondents stating that the virus is “wreaking havoc” as it poses “a major supply chain risk.” Likely due to the timing of the surveys predating the other major outbreaks around the globe, the comments mainly make note of the effects of the virus on operations in China. In other words, seeing as this data is lagged a bit, the full effects of more recent outbreaks outside of Asia (namely China) are not likely to be fully reflected in the February report.
Breadth across the individual categories of the report was on the weaker side with only three improving from January and only two improving versus one year ago. These moves have brought the indices for New Orders, Prices Paid, and Imports all into contraction territory from expansionary readings in the prior month. Again, the headline index did not experience any major shifts as might have been expected as a result of Covid-19, but under the hood, some components are beginning to show a more prominent negative impact.
The worst of those declines were for Imports which fell from 51.3 in January to 42.6. As shown below, that is the weakest reading since the Financial Crisis (May 2009) when it dropped down to 38.5. The 8.7 point decline was also the largest month over month decline on record in the data going back to 1989. This drop is perhaps the most obvious result of Covid-19 disruptions. Shutdowns from the virus in addition to the New Years Holiday in China would have resulted in weaker trade activity. Export orders are echoing this as they declined 2.1 points although that drop was not nearly as large as that of imports.
Supplier deliveries (readings above 50 indicate longer delivery times and under 50 indicate faster deliveries) are giving further evidence to negative impacts from the Coronavirus. The index surged to 57.3 in February from 52.9 in January. That is the highest reading since November 2018 and was the largest one month increase since June of 2018. In other words, suppliers are struggling to deliver due to supply chain disruptions.
As suppliers struggle to deliver, backlogs have begun to grow with the index ticking up to 50.3. That is the first expansionary reading since April of last year. Start a two-week free trial to Bespoke Institutional to access our interactive economic indicators monitor and much more.
Bespoke Market Calendar — March 2020
Please click the image below to view our March 2020 market calendar. This calendar includes the S&P 500’s average percentage change and average intraday chart pattern for each trading day during the upcoming month. It also includes market holidays and options expiration dates plus the dates of key economic indicator releases. Start a two-week free trial to one of Bespoke’s three research levels.





















